Search Results: TRACERx

• For Researchers

Recognising excellence: our 2016 prizewinners

CRUK's research prizes recognise and celebrate outstanding and innovative cancer researchers. CRUK's research prizes recognise and celebrate outstanding and innovative cancer researchers.

20 June 2017

• Health & Medicine

Experimental blood test could offer a glimpse of the future for doctors treating lung cancer

An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment. An experimental blood test could offer a way to detect early signs that patients’ lung cancers will return after treatment.

26 April 2017

• Science & Technology

Tracing genetic chaos in 100 lung cancer patients could help predict survival

By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival. By tracing genetic chaos over time our scientists may have found a way to help predict lung cancer survival.

26 April 2017

• Science & Technology
• Health & Medicine

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

26 April 2017

• Charity News

New Year honours for Cancer Research UK experts

The New Year honours list includes three Cancer Research UK experts who are being recognised for their service to science. The New Year honours list includes three Cancer Research UK experts who are being recognised for their service to science.

31 December 2016

• Health & Medicine

Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer

Syncona LLP and Cancer Research Technology (CRT) announce the formation of Achilles Therapeutics Ltd today. Syncona LLP and Cancer Research Technology (CRT) announce the formation of Achilles Therapeutics Ltd today.

5 October 2016

• For Researchers

Remarkable PhD student awarded Pontecorvo prize

This year’s Pontecorvo prize for Best PhD Thesis has been awarded to Dr Nicholas McGranahan, an outstanding young scientist at UCL and the Crick. This year’s Pontecorvo prize for Best PhD Thesis has been awarded to Dr Nicholas McGranahan, an outstanding young scientist at UCL and the Crick.

22 July 2016

• Health & Medicine

Tackling hard-to-treat cancers – what, how and why?

Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours. Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.

20 July 2016

• Science & Technology
• Health & Medicine

Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres

We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor. We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.

13 May 2016

• Science & Technology

Post-mortem cancer study goes national

Cancer Research UK invests £4 million investment to expand the UK’s first ever national study collecting blood and tissue samples from patients who have died. Cancer Research UK invests £4 million investment to expand the UK’s first ever national study collecting blood and tissue samples from patients who have died.

13 May 2016

• Science & Technology

Everything you really need to know about DNA sequencing

We explore how we got to where we are today with DNA sequencing and the science behind it. We explore how we got to where we are today with DNA sequencing and the science behind it.

25 April 2016

"Surprised and deeply honoured" - our chief executive receives a knighthood

Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research

30 December 2015